James E. Hall
23Patents
8h-index
14Co-inventors
68Inventor score
Filing activity: Oct 25, 1988 → Jul 30, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4933347A | Diamidines and bis(imidazolines) for the treatment of and prophylaxis against pneumocystis carinii pneumonia | Chemistry; Metallurgy | 33 | Expired |
| US5521189A | Methods of treating pneumocystis carinii pneumonia | Emerging Cross-Sectional Technologies | 26 | Expired |
| US6172104A | Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof | Chemistry; Metallurgy | 23 | Expired |
| US5602172A | Methods of inhibiting Pneumocystis carinii pneumonia, Giardia lamblia, and Cryptosporidium and compounds useful therefor | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5428051A | Methods of combating pneumocystis carinii pneumonia and compounds useful therefor | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5843980A | Benzamidoxime prodrugs as antipneumocystic agents | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5723495A | Benzamidoxime prodrugs as antipneumocystic agents | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6635668B1 | Imidazoline receptor binding compounds | Physics | 9 | Expired |
| US5668166A | Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5668167A | Methods of treating microbial infections | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5202320A | Method for treating leishmaniasis | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5627184A | Methods of treating Giardia lamblia | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5622955A | Methods of treating cryptosporidium parvum | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5606058A | Compounds for the treatment of pneumocystis carinii Pneumonia, Giardia Lamblia, and Cryptospordium parnum | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5686456A | Methods of treating pneumocystis carinii pneumonia | Emerging Cross-Sectional Technologies | 6 | Expired |
| US6025398A | Benzamidoxime prodrugs as antipneumocystic agents | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6649652B2 | Prodrugs for antimicrobial amidines | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5206236A | Method for the treatment of malaria | Emerging Cross-Sectional Technologies | 4 | Expired |
| US6214883A | Benzamidoxime prodrugs as antipneumocystic agents | Emerging Cross-Sectional Technologies | 4 | Expired |
| US5578631A | Methods of combating Pneumocystis carinii pneumonia and compounds useful therefor | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6423737B1 | Benzamidoxime prodrugs as antipneumocystic agents | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6503940B2 | Prodrugs for antimicrobial amidines | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6486200B1 | Prodrugs for antimicrobial amidines | Emerging Cross-Sectional Technologies | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.